Zarontin 250 mg/5mL
Ethosuximide · SOLUTION · Parke-Davis Div of Pfizer Inc
No Recall History
Plain English
Zarontin is a solution containing ethosuximide at 250 mg/5mL, taken oral. Manufactured by Parke-Davis Div of Pfizer Inc.
Key Facts
- Brand Name
- Zarontin
- Generic Name
- Ethosuximide
- NDC Code (Product)
0071-2418- Manufacturer
- Parke-Davis Div of Pfizer Inc
- Strength
- 250 mg/5mL
- Dosage Form
- SOLUTION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA080258
- Drug Class
- Anti-epileptic Agent [EPC]
- Marketing Start
- 03/10/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Zarontin used for?
Zarontin contains Ethosuximide. It is a solution taken oral. Consult your doctor for specific uses.
Is Zarontin a controlled substance?
Zarontin is not classified as a controlled substance by the DEA.
What is the generic name for Zarontin?
The generic name for Zarontin is Ethosuximide. There are 9 other brand versions of Ethosuximide.
What is the NDC code for Zarontin 250 mg/5mL?
The NDC (National Drug Code) for Zarontin 250 mg/5mL is 0071-2418, listed by Parke-Davis Div of Pfizer Inc.